首页> 美国卫生研究院文献>Journal of Diabetes Science and Technology >Clinical Evaluation of the Use of a Multifunctional Remotely Controlled Insulin Pump
【2h】

Clinical Evaluation of the Use of a Multifunctional Remotely Controlled Insulin Pump

机译:多功能遥控胰岛素泵使用的临床评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Current insulin pumps now feature advanced functions for calculating insulin dosages, delivering insulin and analyzing data, however, the perceived usefulness of these functions in clinical settings has not been well studied. We assessed the use and patient perceptions of an insulin delivery system (Accu-Chek® Combo, Roche Diagnostics, Mannheim, Germany) that combines an insulin pump and a handheld multifunctional blood glucose meter with integrated remote control functions. This prospective, observational, multicenter study enrolled 74 type 1 diabetes patients within 13 weeks after starting use of the pump system. At 4 to 24 weeks, investigators collected usage data from the latest 14-day period. Seventy-two patients completed the evaluation, aged 39 ± 15 years, diabetes duration 16 ± 13 years, HbA1c 8.3 ± 1.6%. At follow-up, 62 (86.1%) patients used the remote control for ≥50% of all boluses, 20 (27.8%) used the bolus advisor for ≥50% of all boluses, and 42 (58.3%) viewed at least 1 of the e-logbook reports. More than 95% of users appraised the functions as easy-to-use and useful; median scores from VAS (0 = useless to 100 = indispensable) ranged from 72 to 85. A high percentage of study patients used the system’s advanced features, especially the remote control feature for bolusing. Overall, patients assessed the functions as useful and easy to use. Results support the implementation of these smart capabilities in further insulin pump developments.
机译:当前的胰岛素泵现在具有用于计算胰岛素剂量,输送胰岛素和分析数据的高级功能,但是,尚未对这些功能在临床环境中的有用性进行深入研究。我们评估了胰岛素输送系统(Accu-Chek ® Combo,Roche Diagnostics,德国曼海姆,德国)的使用和患者感知,该系统结合了胰岛素泵和集成了远程控制功能的手持式多功能血糖仪。这项前瞻性,观察性,多中心研究在开始使用泵系统后的13周内纳入了74位1型糖尿病患者。在4到24周时,调查人员收集了最近14天的使用情况数据。共有72位患者完成了评估,年龄39±15岁,糖尿病病程16±13岁,HbA1c 8.3±1.6%。随访时,有62(86.1%)名患者使用遥控进行所有推注的≥50%,有20(27.8%)患者使用了推注咨询器的≥50%,并且有42名(58.3%)至少观察到了1电子日志报告。超过95%的用户认为这些功能易于使用和有用。 VAS的中位数得分(0 =无用到100 =必不可少)在72到85之间。很大比例的研究患者使用了该系统的高级功能,尤其是远程控制功能。总体而言,患者认为这些功能有用且易于使用。结果支持在进一步的胰岛素泵开发中实施这些智能功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号